These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 29498821)
1. Intratumoral Injection of Low-Energy Photon-Emitting Gold Nanoparticles: A Microdosimetric Monte Carlo-Based Model. Laprise-Pelletier M; Ma Y; Lagueux J; Côté MF; Beaulieu L; Fortin MA ACS Nano; 2018 Mar; 12(3):2482-2497. PubMed ID: 29498821 [TBL] [Abstract][Full Text] [Related]
2. Low-Dose Prostate Cancer Brachytherapy with Radioactive Palladium-Gold Nanoparticles. Laprise-Pelletier M; Lagueux J; Côté MF; LaGrange T; Fortin MA Adv Healthc Mater; 2017 Feb; 6(4):. PubMed ID: 28116855 [TBL] [Abstract][Full Text] [Related]
3. In silico dosimetry of low-dose rate brachytherapy using radioactive nanoparticles. Seniwal B; Freitas LF; Mendes BM; Lugão AB; Katti KV; Fonseca TCF Phys Med Biol; 2021 Feb; 66(4):045016. PubMed ID: 33561008 [TBL] [Abstract][Full Text] [Related]
4. Monte Carlo simulation of radiation transport and dose deposition from locally released gold nanoparticles labeled with Lai P; Cai Z; Pignol JP; Lechtman E; Mashouf S; Lu Y; Winnik MA; Jaffray DA; Reilly RM Phys Med Biol; 2017 Oct; 62(22):8581-8599. PubMed ID: 29077574 [TBL] [Abstract][Full Text] [Related]
5. A Monte Carlo study of I-125 prostate brachytherapy with gold nanoparticles: dose enhancement with simultaneous rectal dose sparing via radiation shielding. Brivio D; Nguyen PL; Sajo E; Ngwa W; Zygmanski P Phys Med Biol; 2017 Mar; 62(5):1935-1948. PubMed ID: 28140338 [TBL] [Abstract][Full Text] [Related]
6. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code. Bohm TD; DeLuca PM; DeWerd LA Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition. Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752 [TBL] [Abstract][Full Text] [Related]
8. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer. Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM J Nucl Med; 2016 Jun; 57(6):936-42. PubMed ID: 26848176 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the effects of cell model and subcellular location of gold nanoparticles on nuclear dose enhancement factors using Monte Carlo simulation. Cai Z; Pignol JP; Chattopadhyay N; Kwon YL; Lechtman E; Reilly RM Med Phys; 2013 Nov; 40(11):114101. PubMed ID: 24320476 [TBL] [Abstract][Full Text] [Related]
10. Air-kerma strength determination of a new directional (103)Pd source. Aima M; Reed JL; DeWerd LA; Culberson WS Med Phys; 2015 Dec; 42(12):7144-52. PubMed ID: 26632069 [TBL] [Abstract][Full Text] [Related]
11. Rapid, one-pot procedure to synthesise Djoumessi D; Laprise-Pelletier M; Chevallier P; Lagueux J; Côté MF; Fortin MA J Mater Chem B; 2015 Mar; 3(10):2192-2205. PubMed ID: 32262387 [TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles. Khoo AM; Cho SH; Reynoso FJ; Aliru M; Aziz K; Bodd M; Yang X; Ahmed MF; Yasar S; Manohar N; Cho J; Tailor R; Thames HD; Krishnan S Sci Rep; 2017 Dec; 7(1):18044. PubMed ID: 29273727 [TBL] [Abstract][Full Text] [Related]
13. 103Pd strings: Monte Carlo assessment of a new approach to brachytherapy source design. Rivard MJ; Reed JL; DeWerd LA Med Phys; 2014 Jan; 41(1):011716. PubMed ID: 24387508 [TBL] [Abstract][Full Text] [Related]
14. Tumor dose enhancement by nanoparticles during high dose rate (192)Ir brachytherapy. Zabihzadeh M; Arefian S J Cancer Res Ther; 2015; 11(4):752-9. PubMed ID: 26881513 [TBL] [Abstract][Full Text] [Related]
15. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279 [TBL] [Abstract][Full Text] [Related]
16. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources. Cho SH; Jones BL; Krishnan S Phys Med Biol; 2009 Aug; 54(16):4889-905. PubMed ID: 19636084 [TBL] [Abstract][Full Text] [Related]
17. Dosimetric consequences of gold nanoparticle clustering during photon irradiation. Kirkby C; Koger B; Suchowerska N; McKenzie DR Med Phys; 2017 Dec; 44(12):6560-6569. PubMed ID: 28994464 [TBL] [Abstract][Full Text] [Related]
18. Multiscale Monte Carlo simulations of gold nanoparticle dose-enhanced radiotherapy I: Cellular dose enhancement in microscopic models. Martinov MP; Fletcher EM; Thomson RM Med Phys; 2023 Sep; 50(9):5853-5864. PubMed ID: 37211878 [TBL] [Abstract][Full Text] [Related]
19. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study. Saidi P; Sadeghi M; Shirazi A; Tenreiro C Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862 [TBL] [Abstract][Full Text] [Related]
20. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect. Abboud F; Scalliet P; Vynckier S Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]